Velayos-Baeza Antonio, Holinski-Feder Elke, Neitzel Birgit, Bader Benedikt, Critchley Edmund M R, Monaco Anthony P, Danek Adrian, Walker Ruth H
The Wellcome Trust Centre for Human Genetics, Oxford, England.
Arch Neurol. 2011 Oct;68(10):1330-3. doi: 10.1001/archneurol.2011.239.
To determine the molecular nature of the neurological disease in the seminal family reported by Critchley et al in the 1960s, characterized by a hyperkinetic movement disorder and the appearance of acanthocytosis on peripheral blood smear. The eponym Levine-Critchley syndrome, subsequently termed neuroacanthocytosis, has been applied to symptomatically similar, but genetically distinct, disorders, resulting in clinical and diagnostic confusion.
DNA analysis.
Molecular biology research laboratories.
First- and second-degree relatives of the original Critchley et al proband from Kentucky.
Mutations in the VPS13A gene.
A mutation was identified in the VPS13A gene, responsible for autosomal recessive chorea-acanthocytosis. Haplotype reconstruction suggested that this mutation was homozygous in the proband.
These findings strongly support the diagnosis of chorea-acanthocytosis as the disorder described in the original report.
确定20世纪60年代克里奇利等人报告的一个家族性神经疾病的分子本质,该疾病的特征为运动障碍亢进以及外周血涂片出现棘红细胞增多。曾被称为莱文-克里奇利综合征(后称为神经棘红细胞增多症)的病名已用于症状相似但基因不同的疾病,导致临床和诊断上的混淆。
DNA分析。
分子生物学研究实验室。
来自肯塔基州的最初克里奇利等人研究的先证者的一级和二级亲属。
VPS13A基因中的突变。
在VPS13A基因中鉴定出一个突变,该突变导致常染色体隐性遗传性舞蹈病-棘红细胞增多症。单倍型重建表明该突变在先证者中为纯合子。
这些发现有力地支持了将舞蹈病-棘红细胞增多症诊断为原始报告中描述的疾病。